244 related articles for article (PubMed ID: 23943578)
1. [Resection or interventional treatment of hepatocellular carcinoma: which method for which patient?].
Lang H; Ricke J; Schlaak J
Dtsch Med Wochenschr; 2013 Sep; 138(36):1780-4. PubMed ID: 23943578
[No Abstract] [Full Text] [Related]
2. Sorafenib in combination with transarterial chemoembolization for the treatment of hepatocellular carcinoma.
Geschwind JF; Chapiro J
Clin Adv Hematol Oncol; 2016 Aug; 14(8):585-7. PubMed ID: 27487101
[No Abstract] [Full Text] [Related]
3. Liver tumors and loco-regional therapy.
Vogel W
Wien Med Wochenschr; 2013 Mar; 163(5-6):107-8. PubMed ID: 23456251
[No Abstract] [Full Text] [Related]
4. Transarterial chemoembolization and sorafenib in patients with intermediate-stage hepatocellular carcinoma: time to enter routine clinical practice?
Sacco R; Antonucci M; Bargellini I; Marceglia S; Mismas V; Cabibbo G
Future Oncol; 2015; 11(17):2371-3. PubMed ID: 26270206
[No Abstract] [Full Text] [Related]
5. JAMA PATIENT PAGE. Treatment of Liver Cancer.
Mokdad AA; Singal AG; Yopp AC
JAMA; 2016 Jan; 315(1):100. PubMed ID: 26746473
[No Abstract] [Full Text] [Related]
6. Clinical value of continuous administration of sorafenib in combination with modified transarterial chemoembolization in patients with unresectable hepatocellular carcinoma.
Huang YH; Chen W; Li JP; Chen B; Yang JY
Chin Med J (Engl); 2013 Jan; 126(2):385-6. PubMed ID: 23324295
[No Abstract] [Full Text] [Related]
7. [Hepatocellular Carcinoma: therapeutic options 2015].
Schultheiß M; Bettinger D; Neeff HP; Brunner TB; Thimme R
Dtsch Med Wochenschr; 2015 Jul; 140(14):1063-8. PubMed ID: 26182255
[TBL] [Abstract][Full Text] [Related]
8. The SIRveNIB and SARAH trials and the role of SIR-Spheres® Y-90 resin microspheres in the management of hepatocellular carcinoma.
Chow PK; Gandhi M; Gebski V
Future Oncol; 2017 Oct; 13(25):2213-2216. PubMed ID: 28976206
[No Abstract] [Full Text] [Related]
9. Downstaging hepatocellular carcinoma prior to liver transplantation.
Gamblin TC; Geller DA
Liver Transpl; 2005 Dec; 11(12):1466-8. PubMed ID: 16315292
[No Abstract] [Full Text] [Related]
10. Major achievements in hepatocellular carcinoma.
Bruix J; Llovet JM
Lancet; 2009 Feb; 373(9664):614-6. PubMed ID: 19231618
[No Abstract] [Full Text] [Related]
11. Surgical resection and liver transplantation for hepatocellular carcinoma.
Akoad ME; Pomfret EA
Clin Liver Dis; 2015 May; 19(2):381-99. PubMed ID: 25921669
[TBL] [Abstract][Full Text] [Related]
12. Managing localized unresectable hepatocellular carcinoma.
Narang-Master J; Rizzolo D
JAAPA; 2015 Jan; 28(1):27-34. PubMed ID: 25486501
[TBL] [Abstract][Full Text] [Related]
13. Multidisciplinary Approach in Hepatocellular Carcinoma in a Level II Hospital: The First Decade of Hospital Universitario Fundacion Alcorcon.
Loinaz Segurola C; LIedó Navarro JL; Burgos Rde L; Martín Ríos D; Ochando Cerdán F; Alonso López S; Martel Villagrán J; Gutiérrez Garcia ML; Fernandez Cebrián JM; Fernández Rodríguez C
Hepatogastroenterology; 2015 Jun; 62(140):971-7. PubMed ID: 26902039
[TBL] [Abstract][Full Text] [Related]
14. Management of hepatocellular carcinoma.
Del Pozo AC; López P
Clin Liver Dis; 2007 May; 11(2):305-21. PubMed ID: 17606209
[TBL] [Abstract][Full Text] [Related]
15. Multimodality treatment involving radiotherapy for advanced liver-confined hepatocellular carcinoma.
Yoon HI; Seong J
Oncology; 2014; 87 Suppl 1():90-8. PubMed ID: 25427739
[TBL] [Abstract][Full Text] [Related]
16. Optimal timing of combining sorafenib with locoregional treatments in patients with advanced hepatocellular carcinoma.
Kim EH; Kim BK; Kim DY; Kim SU
Eur J Gastroenterol Hepatol; 2013 Apr; 25(4):514-5. PubMed ID: 23466449
[No Abstract] [Full Text] [Related]
17. Heterogeneity of patients with intermediate (BCLC B) Hepatocellular Carcinoma: proposal for a subclassification to facilitate treatment decisions.
Bolondi L; Burroughs A; Dufour JF; Galle PR; Mazzaferro V; Piscaglia F; Raoul JL; Sangro B
Semin Liver Dis; 2012 Nov; 32(4):348-59. PubMed ID: 23397536
[TBL] [Abstract][Full Text] [Related]
18. Combined transcatheter arterial embolization and expanded liver resection for hepatocellular carcinoma with multiple intrahepatic metastasis.
Tanaka A; Kumada K; Yamaoka Y; Ozawa K
Am J Gastroenterol; 1992 Oct; 87(10):1496-8. PubMed ID: 1329496
[TBL] [Abstract][Full Text] [Related]
19. Right sided heart mass reveals hepatocellular carcinoma.
Barbero C; Salizzoni S; Centofanti P; Molino F; Campisi P; Giorgi M; Rinaldi M
Heart Lung Circ; 2012 Dec; 21(12):817-8. PubMed ID: 22841160
[No Abstract] [Full Text] [Related]
20. Chemoembolization and bland embolization: a critical appraisal.
Befeler AS
Clin Liver Dis; 2005 May; 9(2):287-300, vii. PubMed ID: 15831274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
